Navigation Links
EU presidency focuses on rheumatic and musculoskeletal diseases

On 19 October 2010, experts from academia, scientific societies, patient organisations, Member States' government and social security institutions as well as EU bodies agreed upon a number of key policy recommendations for improving the management and prevention of rheumatic and musculoskeletal diseases (MSKD). This set of recommendations, and specific initiatives for their implementation, were the main outcomes of the EU Presidency Conference on MSKD, organised in collaboration with EULAR, the European League Against Rheumatism. The recommendations embraced six areas of intervention: MSKD on health policy agendas; rights of patients to healthcare and to full inclusion in economic and social life; early prevention; evidence-based treatment and standards of care; patient involvement in the design, implementation and evaluation of healthcare services; and research. Conference recommendations culminated in the call for an EU Musculoskeletal Disease Strategy and national action plans.

Consensus was reached among participants concerning recognition of the socioeconomic importance of MSKD and the need for prioritising MSKD on health policy agendas. As EULAR President Prof. Paul Emery stated, "MSKD should be recognised as one of the most important public health challenges, given the enormous burden of these disorders on individuals' lives, the social and health systems, and thereby the whole economy".

The conference underlined the importance of active patient involvement. Access to health care services and full inclusion in society have to be recognised as entitlements of citizens with such disorders. However, as several speakers pointed out, much effort is still needed to guarantee equal access to treatment as well as integration into the labour market. Employers were called upon to allow for adaptations of work environments and working conditions. Such flexibility at work places would enable people to stay in work or return to work instead of being excluded.

Delegates also made the case for concrete actions on prevention. The impact of musculoskeletal diseases could in many cases be limited if people affected by them benefited from early referral and early diagnosis. Well trained general practitioners and specialists as well as a sufficient number of specialised centres, were mentioned as key elements to serve this purpose.

According to participants, EU institutions and Member States should guarantee that the management of chronic diseases, and particularly MSKD, is organised in accordance with evidence-based recommendations. Moreover, standards of care should be further developed and implemented across Europe.

Special attention was given to the role of patients in both prevention and management of musculoskeletal diseases. It was emphasized that patients should be more involved in the design, implementation and evaluation of healthcare services, and that new forms of doctor/patients partnership should be developed. Neil Betteridge, Vice President of the EULAR Standing Committee of People with Arthritis and Rheumatism in Europe (PARE), said: "The involvement of patients represents benefits in two different ways. First, it promotes self-management and self-sufficiency, which are essential for coping with our own diseases. Second, as we are experts in living with these conditions, we can make a significant contribution in designing and evaluating preventive initiatives and treatments".

Delegates also recognised the need for a stronger commitment of both Member States and EU institutions to support and fund basic and applied research in this area. It was stressed that it is not only important to improve knowledge on the determinants of these disorders, but also knowledge and technologies in the fields of prevention and treatment.

EULAR President Prof. Emery presented the conference recommendations at the Ministerial Conference "Innovative approaches for chronic illness in Public Health and Healthcare systems", organised by the Belgian EU Presidency on the following day. Summarising the two days, Prof. Emery declared: "Our community is very satisfied with the results of these two conferences. We can see that Europe is finally recognising the dimension and impact of musculoskeletal disorders. All actors should now work together to implement the excellent ideas exchanged here into daily practice."


Contact: Rory Berrie
European League Against Rheumatism

Related medicine news :

1. Study focuses on mephedrone use in Northern Ireland post-ban
2. American Chemical Society Webinar focuses on NSFs small business funding programs
3. American Chemical Society Webinar focuses on providing scientific advice to the film industry
4. Program focuses on anti-cancer stem cell therapies
5. New Medic Monthly Course Focuses on DNR Orders for Patients with Terminal Illness
6. Symposium focuses on patient safety in CT scanning
7. ACS Webinar focuses on drug discovery process for small molecule therapeutics
8. Brain cancer: Study focuses on forgotten cells
9. ACS Webinar focuses on immigration law for scientific professionals
10. Conference Focuses on Aligning Two Smartest, Most Expensive Operations
11. New Cancer-Fighting Strategy Focuses On Signaling Molecules
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... the "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural ... Structural electronics involves electronic and/or ... protective structures, replacing dumb structures such as vehicle ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
Breaking Medicine Technology: